SPOC Biosciences

SPOC Biosciences is an early-stage biotech founded in 2020, pioneering a high-throughput proteomics platform that integrates on-chip protein synthesis with real-time biosensing. Its core technology, the SPOC Platform, is designed to produce and characterize thousands of proteins simultaneously, promising a 100x scale improvement and a 90% cost reduction over conventional recombinant protein workflows. The company is currently in a pre-revenue, platform development stage, offering early access to select customers to generate large-scale kinetic data critical for AI drug discovery and therapeutic optimization.

The SPOC Platform is an integrated system that synthesizes thousands of full-length, folded proteins directly on a biosensor chip, enabling high-throughput, real-time analysis of protein binding kinetics (e.g., via SPR) at a claimed 90% cost reduction.

SPOC competes with traditional CROs offering protein production and SPR services, as well as with high-throughput proteomics companies (e.g., Nautilus Biotechnology, Seer) and display technology providers. Its unique integration of synthesis and sensing on-chip is a differentiating factor, but it must prove scalability and cost advantages against entrenched workflows.